India remains engaged with US as Trump proposes Section 301 tariffs

The United States Trade Representative (USTR) has concluded investigations against 60 economies, including India, regarding measures of these economies to prevent the import of goods. As a result, the USTR has proposed imposing additional tariffs on imports from the 60 economies under Section 301 of the U.S. Trade Act of 1974. Products covered under section 232 tariffs and certain other products are excluded from these tariff proposals. A special mechanism has also been proposed for textile and apparel products that could allow a certain volume of imports from selected economies to enter the U.S. at lower tariff rates.
As per the report, the proposed tariffs are not yet final and stakeholders can submit requests to participate in public hearings by 22 June 2026. Written comments can be submitted until 6 July 2026. Public hearings will be held on 7 July 2026. The USTR will consider the comments and testimony received before taking a final decision on the proposed measures. Chairman, EEPC India, Pankaj Chadha says, "Reciprocal tariffs are now deemed illegal. After that, IEEPA tariffs under Section 122 were imposed, which the lower court declared illegal."

#WATCH | Mumbai, Maharashtra: On USTR (United States Trade Representative) proposes an additional 12.5% tariff on India, Chairman, EEPC India, Pankaj Chadha says, "... Reciprocal tariffs are now deemed illegal. After that, IEEPA tariffs under Section 122 were imposed, which the… pic.twitter.com/lv6mwzlR4Z

— ANI (@ANI) June 3, 2026

India remains engaged with the U.S. on the matter as a part of Section 301 proceedings. India is also parallelly engaged with the US for finalisation of a framework agreement as was announced on 2nd February 2026 and in accordance with the joint statement released on 7th February 2026.

Meanwhile,United States Ambassador to India Sergio Gor has said that 99 per cent of the proposed India-US interim trade agreement has been finalised and both sides are working to resolve the remaining issues. Speaking at the Citi 2026 India Conference in Mumbai on Wednesday, Gor expressed confidence that the agreement could be concluded within the next few weeks. 
Gor said the proposed agreement would create new opportunities for businesses and workers in both countries. He also pointed to the expansion plans of major American companies in India and noted that more than 40 percent of generic medicines used in the United States are sourced from India. On recent US tariff measures, Mr Gor clarified that they are part of a broader global trade review process and are not aimed specifically at India. He expressed confidence that the agreement would further strengthen economic ties between the two countries.
A US trade delegation led by chief negotiator Brendan Lynch is currently in New Delhi for a three-day round of talks with Indian negotiators headed by Commerce Ministry Additional Secretary Darpan Jain.